Indiana’s needle exchange programs are on the chopping block
Clinical Scorecard: Proposed Cuts to Needle Exchange Initiatives in Indiana
At a Glance
| Category | Detail |
|---|
| Condition | Injection drug use-related infections and overdose |
| Key Mechanisms | Syringe exchange programs providing clean needles, naloxone distribution, and linkage to treatment |
| Target Population | People who inject drugs in Indiana |
| Care Setting | Community-based syringe exchange sites and AIDS service organizations |
Key Highlights
- Syringe exchange programs in Indiana have reduced hepatitis C cases by about 60% and decreased new HIV infections from injection drug use.
- More than 47,000 doses of naloxone were distributed between 2024 and 2025, reversing approximately 1,700 overdoses.
- Legislation (Senate Bill 91) aims to extend syringe exchange programs statewide, but faces opposition citing concerns about facilitating drug use.
Guideline-Based Recommendations
Diagnosis
- Track and monitor hepatitis C and HIV infections related to injection drug use through public health data.
Management
- Provide free and anonymous syringe exchange services to reduce needle sharing and infection transmission.
- Distribute naloxone to participants to reverse opioid overdoses.
- Connect participants to treatment programs for substance use disorder and hepatitis C care.
Monitoring & Follow-up
- Collect data on program usage, infection rates, and naloxone administration outcomes to evaluate effectiveness.
Risks
- Potential concerns about increased needle litter and perceived facilitation of drug use, though evidence supports public health benefits.
Patient & Prescribing Data
Individuals who inject drugs participating in syringe exchange programs
Access to clean needles and naloxone, combined with supportive services, facilitates recovery and reduces overdose deaths and infections.
Clinical Best Practices
- Maintain low-barrier, anonymous access to syringe exchange services without residency or ID requirements.
- Integrate harm reduction supplies with referrals to treatment and medical care.
- Educate participants on safe injection practices and overdose prevention.
- Secure sustainable funding sources beyond taxpayer dollars to support program continuity.
References
